An Extension Study of S-606001 in Participants With Late-onset Pompe Disease (LOPD)
NCT07750990
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Pompe Disease
Interventions
DRUG:
S-606001
DRUG:
ERT
Sponsor
Shionogi